February 14, 2011 — The American College of Physicians (ACP) has issued a new clinical guideline for glycemic control in hospitalized patients that discourages the use of intensive insulin therapy ...
Associate Professor of Medicine, Associate Division Director for Critical Care, Emory University, Atlanta, Georgia; Director, Medical and Coronary Intensive Care, Grady Memorial Hospital, Atlanta, ...
Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for ...
Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition and in ...
The MarketWatch News Department was not involved in the creation of this content.-- Study assessing PharmaSens all-in-one insulin patch pump provides first evidence that combining ...
The majority of patients with type 2 diabetes (T2D) have less than ideal metabolic control despite our greater understanding of the underlying pathophysiologic mechanisms of hyperglycemia and the ...
CEO Sarah Howell talked with Proactive’s Stephen Gunnion about the company’s progress in developing next-generation treatments for diabetes and other cardio metabolic diseases, with a particular focus ...
With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results